Effects of Channa Striata Extract on Intestinal Inflammation and Nutritional Status in Malnutritional Toddlers After Albendazole Therapy in South Bangka District

Launched by INDONESIA UNIVERSITY · Apr 10, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how a special extract from snakehead fish, along with a food supplement called inbumin forte, can help improve the health and nutrition of malnourished children aged 1.5 to 5 years old after they have received a treatment called Albendazole. The study aims to see if these supplements can reduce intestinal inflammation and help children gain weight and improve their overall nutritional status compared to a placebo, which is a substance that looks like the real treatment but doesn’t contain any active ingredients.

To participate, children must be malnourished and their parents or guardians need to be willing to take part and able to complete some questionnaires. Unfortunately, children with certain chronic illnesses, allergies to snakehead fish, or disabilities that make it hard to gather information cannot join. Over three months, participants will take the supplements daily, and researchers will check their height and weight each month, as well as collect stool and blood samples at the end of the study to see how they have improved. This trial aims to find better ways to support malnourished children and help them grow healthier.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Malnourished children aged 1.5-5 years (-3SD to \< -2 SD)
• • Parents or guardians are willing to participate in the study
• • Parents or guardians can read and fill out the questionnaire
• Exclusion Criteria:
• • Children with chronic diseases such as tuberculosis, congenital heart disease, diabetes, cancer, epilepsy, HIV Aids, sickle cell anemia, and mental illness.
• • Children with history of snakehead fish allergy
• • Children with physical disabilities that complicate data collection